Recall Register

Food, drugs, devices › Philips Electronics North America Corporation

Device recall: IntelliVue MX40 Patient Monitor, Software Versions B.05, B.06, B.06.5X, Model 865350

FDA enforcement event 80064 · Class II · initiated 30 Apr 2018 · status Terminated · terminated 4 Oct 2019

DeviceVoluntary: Firm initiated4 product recordsAndover, MA

FDA enforcement event 80064 is a device recall by Philips Electronics North America Corporation of Andover, MA, initiated 30 Apr 2018 and classified Class II, with 4 product records.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 92% of the 1,074 device enforcement events initiated in 2018 carry the same class.

Status: Terminated, terminated 4 Oct 2019. Initiation: voluntary: firm initiated. Philips Electronics North America Corporation has 61 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Philips Electronics North America Corporation, Andover, MA.

Reason for recall

"Five warning statements are missing from the instructions for use."

Distribution

"Worldwide Distribution -- US, to the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-2141-2018IntelliVue MX40 Patient Monitor, Software Versions B.05, B.06, B.06.5X, Model 86535025,499Class IITerminated20 Jun 2018
Z-2142-2018IntelliVue MX40 Patient Monitor, Software Versions B.05, B.06, B.06.5X, Model 8653517,178Class IITerminated20 Jun 2018
Z-2143-2018IntelliVue MX40 Patient Monitor, Software Versions B.05, B.06, B.06.5X, Model 8653524,488Class IITerminated20 Jun 2018
Z-2144-2018IntelliVue MX40 Patient Monitor, Software Versions B.05, B.06, B.06.5X, Model 86714694Class IITerminated20 Jun 2018

Context

92%of 2018 device events are Class II1,074 events that year
4product records in this eventfirm median: 1
61events on this register for the firm

Other enforcement events for Philips Electronics North America Corporation

InitiatedProduct (first record)TypeClassRecords
15 Nov 2018Xper Flex Cardio Physiomonitoring System, Software versions 1.5.16.0322 and 1.6.1.0390, Model Numbers 453564241901, 4535DeviceClass II1
10 Oct 2018IntelliVue MX40 Patient Monitor, Model Nos. 865350, 865351, 865352, 867146 - Product Usage: Indicated for use by health DeviceClass II1
16 Jul 2018INTEGRIS Allura 9, System Code 722018 Vascular, cardiovascular and neurovascular imaging applications, Cardiac imaging aDeviceClass II27
13 Jul 2018Philips SureSigns VSV (Vital Signs Viewer), 863067 Indicated for central monitoring of multiple adult, pediatric and neoDeviceClass II5
3 May 2018HeartStart MRx Monitor/Defibrillator, Model No. M3535A (861288), M3536A (861289) Product Automated external defibrillatoDeviceClass II1
16 Mar 2018Multiva systems, 1) Multiva 1.5T 8 R5 Model 781072, 2) Multiva 1.5T 16 R5 Model 781073, 3) Multiva 1.5T 8ch R5 based ModDeviceClass II13
14 Mar 2018Allura Xper R8.x.25.5 and UNIZ systems (only with a FlexVision large screen monitor), Interventional fluoroscopic x-ray DeviceClass II1
7 Feb 2018HeartStart XL+ Defibrillator/Monitor The HeartStart XL+ is intended for use in a hospital setting by qualified medical pDeviceClass III1
29 Jan 2018Philips QCPR Meter - used with FR3 Product Usage: The Philips CPR meter is intended for use with the Philips HeartStart DeviceClass II2
4 Jan 2018Allura Xper systems with Certeray X-ray Generator located in regions with high mains (480V) voltage. Product Usage: The DeviceClass II1

All 61 events for Philips Electronics North America Corporation

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Five warning statements are missing from the instructions for use."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution -- US, to the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR,…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 4 Oct 2019. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.